“We take this decision very seriously. We know this is a decision that’s going to impact multiple generations. I’ve traveled the world for Bayer, and I’m often in plants that are more than 100 years old, so this is a decision that will outlive us all. You’ve created a great environment for a mission-oriented company like ours. In the U.S. alone, we’ve treated 4.5 million people with our prescription medicines in the last three years. We want to grow that level a lot, both here in the U.S. and abroad. New Albany is a great place to do that with the life science expertise and the friendly business climate that you’ve built. After a competitive global review, we’re happy to expand our production footprint here. We see a tremendous chance to build the biopharma ecosystem here and partner with your research institutions.”

– Bill Anderson, CEO
Bayer